-
Je něco špatně v tomto záznamu ?
The natural cytokinin 2OH3MeOBAR induces cell death by a mechanism that is different from that of the "classical" cytokinin ribosides
J. Voller, T. Béres, M. Zatloukal, PA. Kaminski, P. Niemann, K. Doležal, P. Džubák, M. Hajdúch, M. Strnad,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- adenosin analogy a deriváty chemie farmakologie MeSH
- apoptóza účinky léků MeSH
- buněčná smrt účinky léků MeSH
- cytokininy chemie farmakologie MeSH
- glykosidy farmakologie MeSH
- isopentenyladenosin farmakologie MeSH
- kinetin farmakologie MeSH
- molekulární struktura MeSH
- Publikační typ
- časopisecké články MeSH
Cytokinin ribosides (N(6)-substituted adenosines) have demonstrated anticancer activity in various cultured cell lines, several xenografts and even a small clinical trial. Effects of kinetin riboside, N(6)-benzyladenosine (BAR) and N(6)-isopentenyladenosine on various parameters related to apoptosis have also been reported, but not directly compared with those of the highly active naturally occurring aromatic cytokinins oTR (ortho-topolin riboside) and 2OH3MeOBAR (N(6)-(2-hydroxy-3-methoxybenzyl)adenosine). Here we show that 2OH3MeOBAR is the most active cytokinin riboside studied to date (median, 1st quartile, 3rd quartile and range of GI50 in tests with the NCI60 cell panel: 0.19, 0.10, 0.43 and 0.02 to 15.7 μM, respectively) and it differs from other cytokinins by inducing cell death without causing pronounced ATP depletion. Analysis of NCI60 test data suggests that its activity is independent of p53 status. Further we demonstrate that its 5'-monophosphate, the dominant cancer cell metabolite, inhibits the candidate oncogene DNPH1. Synthesis, purification, HPLC-MS identification and HPLC-UV quantification of 2OH3MeOBAR metabolites are also reported.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013274
- 003
- CZ-PrNML
- 005
- 20170426093936.0
- 007
- ta
- 008
- 170413s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.phytochem.2017.01.004 $2 doi
- 035 __
- $a (PubMed)28153445
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Voller, Jiří $u Laboratory of Growth Regulators, Centre of the Region Haná for Biotechnological and Agricultural Research, Institute of Experimental Botany ASCR & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czechia. Electronic address: jiri.voller@upol.cz.
- 245 14
- $a The natural cytokinin 2OH3MeOBAR induces cell death by a mechanism that is different from that of the "classical" cytokinin ribosides / $c J. Voller, T. Béres, M. Zatloukal, PA. Kaminski, P. Niemann, K. Doležal, P. Džubák, M. Hajdúch, M. Strnad,
- 520 9_
- $a Cytokinin ribosides (N(6)-substituted adenosines) have demonstrated anticancer activity in various cultured cell lines, several xenografts and even a small clinical trial. Effects of kinetin riboside, N(6)-benzyladenosine (BAR) and N(6)-isopentenyladenosine on various parameters related to apoptosis have also been reported, but not directly compared with those of the highly active naturally occurring aromatic cytokinins oTR (ortho-topolin riboside) and 2OH3MeOBAR (N(6)-(2-hydroxy-3-methoxybenzyl)adenosine). Here we show that 2OH3MeOBAR is the most active cytokinin riboside studied to date (median, 1st quartile, 3rd quartile and range of GI50 in tests with the NCI60 cell panel: 0.19, 0.10, 0.43 and 0.02 to 15.7 μM, respectively) and it differs from other cytokinins by inducing cell death without causing pronounced ATP depletion. Analysis of NCI60 test data suggests that its activity is independent of p53 status. Further we demonstrate that its 5'-monophosphate, the dominant cancer cell metabolite, inhibits the candidate oncogene DNPH1. Synthesis, purification, HPLC-MS identification and HPLC-UV quantification of 2OH3MeOBAR metabolites are also reported.
- 650 _2
- $a adenosin $x analogy a deriváty $x chemie $x farmakologie $7 D000241
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a buněčná smrt $x účinky léků $7 D016923
- 650 _2
- $a cytokininy $x chemie $x farmakologie $7 D003583
- 650 _2
- $a glykosidy $x farmakologie $7 D006027
- 650 _2
- $a isopentenyladenosin $x farmakologie $7 D007541
- 650 _2
- $a kinetin $x farmakologie $7 D007701
- 650 _2
- $a molekulární struktura $7 D015394
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Béres, Tibor $u Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czechia.
- 700 1_
- $a Zatloukal, Marek $u Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czechia.
- 700 1_
- $a Kaminski, Pierre Alexandre $u The Institut Pasteur, Unité de Biologie des Bactéries Pathogènes à Gram-Positif, Centre National pour la Recherche Scientifique (CNRS) ERL 3526, 75724 Paris, France.
- 700 1_
- $a Niemann, Percy $u BIOLOG Life Science Institute, Flughafendamm 9a, D-28199, Bremen, Germany.
- 700 1_
- $a Doležal, Karel $u Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czechia.
- 700 1_
- $a Džubák, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 5, 77515 Olomouc, Czechia.
- 700 1_
- $a Hajdúch, Marián $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Hněvotínská 5, 77515 Olomouc, Czechia.
- 700 1_
- $a Strnad, Miroslav $u Laboratory of Growth Regulators, Centre of the Region Haná for Biotechnological and Agricultural Research, Institute of Experimental Botany ASCR & Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czechia.
- 773 0_
- $w MED00003829 $t Phytochemistry $x 1873-3700 $g Roč. 136, č. - (2017), s. 156-164
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28153445 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170426094255 $b ABA008
- 999 __
- $a ok $b bmc $g 1199739 $s 974052
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 136 $c - $d 156-164 $e 20170130 $i 1873-3700 $m Phytochemistry $n Phytochemistry $x MED00003829
- LZP __
- $a Pubmed-20170413
